CCL2 and neoplasm: One of the most studied TME factors, chemokine (C-C motif) ligand 2 (CCL2), also known as monocyte chemoattractant protein 1 (MCP-1), is expressed by tumor cells, and its expression correlates with poor prognosis in most human tumors [16,17].